# The Effect of Oxymetazoline Gel on Anal Pressure and Incontinence in Spinal Cord Injury Patients

> **NCT02299557** · PHASE1,PHASE2 · COMPLETED · sponsor: **RDD Pharma Ltd** · enrollment: 19 (actual)

## Conditions studied

- Fecal Incontinence
- Spinal Cord Injury

## Interventions

- **DRUG:** Oxymetazoline gel
- **DRUG:** Placebo gel

## Key facts

- **NCT ID:** NCT02299557
- **Lead sponsor:** RDD Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-06
- **Final completion:** 2015-07
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2015-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02299557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02299557, "The Effect of Oxymetazoline Gel on Anal Pressure and Incontinence in Spinal Cord Injury Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02299557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*